Global Drug Abuse Testing Market to Reach USD 12.5 Billion by 2033, Propelled by Rising Drug Production and Consumption

December 23, 2024 | Healthcare

IMARC Group’s latest report, titled “Drug Abuse Testing Market Report by Product (Analyzers, Rapid Testing Devices, Consumables, Laboratory Services), Sample (Urine, Oral Fluid (Saliva), Hair, Breath, and Others), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, Workplaces, and Others), and Region 2025-2033,” finds that the global drug abuse testing market size reached USD 7.4 Billion in 2024. A drug abuse test is a non-invasive analysis of biological samples, including blood, hair, and urine, to detect the presence of illegal, prescription drugs or their metabolites. Drug abuse is the intentional use of illegal substances or the excessive use of over-the-counter (OTC) medications and prescribed psychoactive or performance-enhancing substances. Drug abuse testing helps identify infants and children at risk of exposure to illegal drugs and manage cases of acute mental state and seizure in the emergency room. Currently, it finds extensive applications in sports organizations, employers, and forensic purposes across the globe.

Global Drug Abuse Testing Market Trends:

The rising drug production and consumption represents the primary factor driving the market growth. Additionally, the increasing number of individuals consuming alcohol and illicit drugs, such as marijuana, cocaine, and opioids, is positively influencing market growth. Moreover, drugs such as opiates, cannabinoids, cocaine, alcohol, diazepam, lysergic acid diethylamide (LSD), barbiturates, amphetamines, and ketamine are abused for their psychological impact, non-therapeutic and medicinal uses, along with other purposes, such as weight loss and enhancing athletic performance. In line with this, the rising drug dependence and substance use disorder has catalyzed market growth. Besides this, drug abuse can pose severe risks to health and safety and lower the morale and productivity of individuals. As a result, the escalating demand for drug abuse testing for employee and job applicant screening to ensure a safe workplace is propelling the market growth. Apart from this, the rising demand for urine drug testing due to rapid expansion in pain management and opioid dependency clinics is another major growth-inducing factor. Furthermore, several key players are launching automated testing and analysis for drug abuse and at-home use kits for instant drug abuse tests, thereby contributing to the market growth. Other factors, including increasing mortality due to drugs, the emerging e-commerce industry, technological advancements in drug screening or testing devices, and stringent government policies mandating drug screening, are also creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach USD 12.5 Billion by 2033, expanding at a CAGR of 5.64% during 2025-2033.

Market Summary:

  • Based on the product, the market has been divided into analyzers (immunoassays analyzers, chromatographic devices, and breath analyzers), rapid testing devices (urine and oral fluid testing devices), consumables, and laboratory services. 
  • On the basis of the sample, the market has been segregated into urine, oral fluid (saliva), hair, breath, and others. 
  • The market has been categorized based on the end user into hospitals, diagnostic laboratories, forensic laboratories, workplaces, and others. 
  • Region-wise, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Omega Laboratories Inc., Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc., and United States Drug Testing Laboratories Inc.
     

Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Product, Sample, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Omega Laboratories Inc., Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc. and United States Drug Testing Laboratories Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Drug Abuse Testing Market to Reach USD 12.5 Billion by 2033, Propelled by Rising Drug Production and Consumption
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials